Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists

Experimental Dermatology

Volumn 9, Issue 2, 2000, Pages 118-124

  Lippert, U ^b   Moller A ^a   Welker, P ^a   Artuc, M ^a   Henz, B M ^a,c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Antihistamines; Corticosteroids; Cytokines; Mast cells

Indexed keywords

AZELASTINE; CETIRIZINE; DEXAMETHASONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 8; LORATADINE; RANITIDINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BASOPHIL; CALCIUM TRANSPORT; CELL LINE; CYTOKINE RELEASE; DOSE RESPONSE; DRUG INHIBITION; HUMAN; MAST CELL LEUKEMIA;

BASOPHILS; CELL LINE; CYTOKINES; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOCORTICOIDS; HISTAMINE H1 ANTAGONISTS; HISTAMINE H2 ANTAGONISTS; HUMANS; LEUKEMIA; MAST CELLS;

EID: 0342700238     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.2000.009002118.x     Document Type: Article

References (40)

1. 1-receptor antagonists). J Allergy Clin Immunol 1992: 90: 705-715.
2. Henz B M, Zuberbier T, Monroe E. Urticaria therapy. In: Henz B M, Zuberbier T, Grabbe J, Monroe E, eds. Urticaria - Clinical, diagnostic and therapeutic aspects. Berlin: Springer, 1997: 161-182.
3. Dorsch W. Delayed phase immediate type hypersensitivity. Boca Raton: CRC Press, 1990.
4. Metcalfe D D, Baram D, Mekori Y A. Mast cells. Physiol Rev 1997: 77: 1033-1079.
5. Moller A, Henz B M, Grützkau A et al. Comparative cytokine gene expression, regulation and release by human mast cells. Immunology 1998: 93: 289-295.
6. Nilsson G, Forsbergnilsson K, Yiang Z, Hallbook F, Nilsson K, Metcalfe D D. Human mast cells express functional TrkA and are a source of nerve growth factor. Eur J Immunol 1997: 27: 2295-2301.
7. Rumsaeng V, Vliagoftis H, Oh C K, Metcalfe D D. Lymphotactin gene expression in mast cells following Fcε receptor I aggregation. J Immunol 1997: 158: 1353-1360.
8. Schroeder J T, MacGlashan D W. New concepts: The basophil. J Allergy Clin Immunol 1997: 99: 429-433.
9. Krüger-Krasagakes S, Möller A, Kolde G, Lippert U, Weber S, Henz B M. Production of interleukin-6 by human mast cells and basophilic cells. J Invest Dermatol 1996: 106: 75-79.
10. 1-antagonist descarboethoxy-loratadine and dexamethasone from human mast and basophilic cell lines. Exp Dermatol 1995: 4: 272-276.
11. Warbrick E V, Thomas A L, Williams C M. The effects of cyclosporin A, dexamethasone and other immunomodulatory drugs on induced expression of IL-3, IL-4 and IL-8 mRNA in a human mast cell line. Toxicology 1997: 116: 211-218.
12. Schmidt-Choudhury A, Furuta G T, Lavigne J A, Galli S J, Wershil B K. The regulation of tumor necrosis factor-α production in murine mast cells: Pentoxyfilline or dexamethasone inhibits IgE-dependent production of TNF-α by distinct mechanisms. Cell Immunol 1996: 171: 140-146.
13. Lippert U, Welker R Krüger-Krasagakes S, Möller A, Henz B M. Modulation of in vitro cytokine release from human leukemic mast cells (HMC-1) by glucocorticoids. Skin Pharmacol 1996: 9: 93-98.
14. Sim T C, Reece L M, Hilsmeier K A, Grant J A, Alam R. Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment. Am J Respir Crit Care Med 1995: 152: 927-933.
15. Hide I, Toriu N, Nuibe T et al. Suppression of TNF-α secretion by azelastine in a rat mast (RBL-2H3) cell line. J Immunol 1997: 159: 2932-2940.
16. Sarmiento E U, Espiritu B R, Gleich G J, Thomas L L. IL-3, IL-5 and granulocyte-macrophage colony-stimulating factor potentiate basophil mediator release stimulated by eosinophil granule major basic protein. J Immunol 1995: 155: 2211-2221.
17. Toppe E, Haas N, Henz B M. Neutrophilic urticaria - clinical features, histological changes and possible mechanisms. Br J Dermatol 1998: 138: 248-253.
18. Durham S R, Ying S, Varney V A et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and granulocyte/ macrophage colony-stimulating factor in nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992: 148: 2390-2394.
19. Hauser U, Wagenmann M, Rudack C, Bachert C. Suppression der IL-8-Sekretion in das Nasensekret durch die spezifische Immuntherapie. Allergologie 1997: 20: 184-191.
20. Bradding R Roberts J A, Britten K M et al. Interleukin-4, -5, and -6 and tumor necrosis factor-α in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994: 10: 471-480.
21. MacLoed J D, Anderson D F, Baddeley S M, Holgate S T, McGill J I, Roche W R. Immunolocalization of cytokines to mast cells in normal and allergic conjunctiva. Clin Exp Allergy 1997: 27: 1328-1334.
22. Butterfield J H, Weiler D, Dewald G, Gleich G J. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leukemia Res 1988: 12: 345-355.
23. Kishi K. A new leukemic cell line with Philadelphia chromosome characterized as basophil precursor. Leuk Res 1985: 9: 382-390.
24. Hamann K, Grabbe J, Welker P, Haas N, Algermissen B. Czarnetzki B M. Phenotypic evaluation of cultured human mast and basophilic cells and of normal human skin mast cells. Arch Dermatol Res 1994: 286: 380-385.
25. Weber S, Babina M, Krüger-Krasagakes S, Grützkau A, Henz B M. A subclone (5C6) of the human mast cell line HMC-1 represents a more mature phenotype than the original cell line. Arch Dermatol Res 1996: 288: 778-782.
26. Möller A, Lippert U, Leßmann D et al. Human mast cells produce IL-8. J Immunol 1993: 151: 3261-3266.
27. Ochensberger B, Daepp G C, Rihs S, Dahinden C A. Human blood basophils produce interleukin-13 in response to IgE-receptor-dependent and independent activation. Blood 1996: 88: 3028-3037.
28. Furitsu T, Tsujima T, Tono T et al. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993: 99: 1736-1744.
29. Büttner C. Henz B M, Sepp N, Grabbe J. Identification of c-kit mutations in adult - but not in childhood onset indolent mastocytosis: a possible explanation for divergent clinical behavior. J Invest Dermatol 1998: 111: 1227-1231.
30. Togumaga K, Nakamura Y, Sakata K et al. Enhanced expression of glyceraldehyde-3-phosphate. Cancer Res 1987: 47: 5616-5619.
31. Yamamura M, Uyemura K, Deans R J et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991: 254: 277-279.
32. Gordon J R, Galli S J. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 1990: 346: 274-276.
33. Krishnaswamy G, Lakshman T, Miller A R et al. Multifunctional cytokine expression by human mast cells: Regulation by T cell membrane contact and glucocorticoids. J Interferon Cytokine Res 1997: 17: 167-176.
34. Bousquet J, Czarlewski W, Danzig M. Antiallergic properties of loratadine: a review. Advances in Therapy 1995: 12: 183-198.
35. 2-receptor on mast cells and basophils. Agents Actions 1982: 12: 263-267.
36. 1-Antagonist, descarbo-ethoxy-loratadine. J Allergy Clin Immunol 1994: 93: 494-500.
37. Fischer M J, Paulussen J J, Kok-Van Esterik J A. Van der Heijden V S, De Mol N J, Janssen L H. Effects of the antiallergies astemizole and norastemizole on FcεRI receptor-mediated signal transduction processes. Eur J Pharmacol 1997: 322: 97-105.
38. Hoshino M, Nakamura Y. The effect of azelastine on the infiltration of inflammatory cells into the bronchial mucosa and clinical changes in patients with bronchial asthma. Int Arch Allergy Immunol 1997: 114: 285-292.
39. Zweiman B, Atkins P C, Moskovitz A, von Allmen C, Cilibert M, Grossman S. Cellular inflammatory responses during immediate, developing, and established late-phase allergic cutaneous reactions: Effects of cetirizine. J Allergy Clin Immunol 1997: 100: 341-347.
40. 1-receptor antagonists in pruritic dermatoses. Allergy 1998: 53: 180-183.